Iniciativa MAPAC (Mejorar la Adecuación de la Práctica Asistencial y Clínica)
Servicio Navarro de Salud - Osasunbidea
Vitamin D screening is recommended in the following situations: a) Differential diagnosis of primary/secondary hyperparathyroidism; b) Possible hypoparathyroidism, hypo/hypercalcemia or hypo/hyperphosphatemia; c) malabsorption syndrome; and d) Patients over 65 years of age who meet at least one of these criteria: being in an institutionalization regime, being confined to their home or being in a prolonged hospital admission regime (>2 months). Vitamin D screening is not recommended in the ...
Iniciativa MAPAC (Mejorar la Adecuación de la Práctica Asistencial y Clínica)
Servicio Navarro de Salud - Osasunbidea
With the currently available evidence, no indications with solid results and minimally relevant and verifiable clinical significance have been identified that can be recommended. Therefore, the use of platelet-rich plasma is NOT recommended in the following indications until solid scientific evidence is generated to support this practice: a) Tendinopathies; b) Osteoarthritis; c) Pseudarthrosis; d) Muscle injury. The use of platelet-rich plasma in the aforementioned indications should be ...
It is recommended to ensure that the most effective tests and treatments are used, and to have access to palliative care and adequate follow-up in patients with non-small cell and small cell lung cancer.
The most frequent complications of blood transfusion are allergic transfusion reactions (ATRs) and febrile nonhemolytic transfusion reactions (FNHTRs), with a combined incidence of approximately 1%-4% per transfusion. ATRs may range in severity from mild urticaria to life-threatening anaphylaxis. FNHTRs manifest as a fever (oral temperature greater than or equal to 38 °C/100.4 °F and an increase of at least 1 °C/1.8° F from pretransfusion values) or chills/rigors. With approximately 17 ...
RECOMMENDATIONS
• Obtain a thorough drug allergy history as many “allergic reactions” can be removed by history alone. Update the medical record if you can confirm a patient has since tolerated PCN or a PCN derivative to which they were previously allergic. Offer a supervised oral challenge if the patient has any concerns.
• Perform PST if a patient has a PCN allergy listed in their chart and the allergy history is unclear. A negative skin test should be followed by a supervised oral ...